Company profile: Trimedyne
1.1 - Company Overview
Company description
- Provider of Holmium:YAG laser systems and compatible optical fibers and handpieces for minimally invasive surgical procedures, including OmniPulse MAX with DoublePulse and OmniPulse Jr; FlexMAX fibers for lithotripsy; VaporMAX side-firing urological fibers; TaperTip complete assemblies for spine and arthroscopy; and Omni Multiuse reusable handpieces.
Products and services
- OmniPulse MAX: Holmium:YAG laser system featuring DoublePulse mode to deliver enhanced energy to hard substances while reducing risk to surrounding tissues during minimally invasive procedures
- FlexMAX Optical Fibers: Holmium-compatible optical fibers used to deliver laser energy for lithotripsy and other medical procedures in minimally invasive surgical applications
- OmniPulse Jr: 30 Watt Holmium:YAG laser system engineered for various surgical applications supporting minimally invasive surgical techniques
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Trimedyne
Adient Medical
HQ: United States
Website
- Description: Provider of absorbable medical devices to prevent pulmonary embolism, including an Absorbable Vascular Filter that captures blood clots in the inferior vena cava for 12 weeks before dissolving into carbon dioxide and water.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Adient Medical company profile →
Truvic Medical
HQ: United States
Website
- Description: Provider of devices for single-session thrombus removal without thrombolytics, including Symphony, a device that uses continuous aspiration and mechanical assistance to engage and disrupt clots, and Prodigy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Truvic Medical company profile →
Navilyst Medical
HQ: United States
Website
- Description: Provider of medical devices focused on fluid management and vascular access, formed from Boston Scientific’s Fluid Management and Vascular Access units. Offers devices including PASV Valve Technology, an expanded line of Xcela Power Injectable PICCs, and NAMIC fluid management products; develops, manufactures, and markets these solutions. Headquartered in Marlborough, MA.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Navilyst Medical company profile →
Endotis
HQ: France
Website
- Description: Provider of cardiovascular therapeutics, discovering, developing, and manufacturing treatments. Also develops small-glyco drugs for thrombosis, oncology, and hematology. Portfolio includes EP217609, a neutralizable anti-coagulant for managing extracorporeal blood circulation during open-heart surgery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Endotis company profile →
Recovery Force
HQ: United States
Website
- Description: Provider of MORPH, an on-body pre recovery and performance enhancement system, developed and manufactured by Recovery Force.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Recovery Force company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Trimedyne
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Trimedyne
2.2 - Growth funds investing in similar companies to Trimedyne
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Trimedyne
4.2 - Public trading comparable groups for Trimedyne
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →